Cambie Surgery Centre adopts Steriwave for orthopedic surgeries

Published 30/06/2025, 07:16
Cambie Surgery Centre adopts Steriwave for orthopedic surgeries

VANCOUVER - Cambie Surgery Centre, one of Canada’s leading private surgical facilities, has implemented Steriwave nasal photodisinfection as the standard of care for orthopedic and plastic surgeries, according to a press release statement from Ondine Biomedical Inc. (AIM:OBI).

The Vancouver-based facility becomes the third private clinic in Canada to routinely use the nasal photodisinfection technology before surgical procedures.

Established in 1996 as Canada’s first free-standing private hospital, Cambie Surgery Centre is accredited with Exemplary Standing by Accreditation Canada.

"At Cambie Surgery Centre, our mission is to provide the highest standard of care for our patients. Adopting nasal photodisinfection aligns perfectly with our commitment to best practices and patient safety," said Kirsty Carpenter, Executive Director of Cambie Surgery Centre.

Steriwave is a five-minute, light-activated antimicrobial therapy that targets pathogens in the nasal cavity. The treatment involves applying a photosensitive agent to each nostril followed by illumination with a specific wavelength of red light.

According to the press release, approximately 69% of surgical site infections are caused by pathogens that colonize the nasal passages. Health authorities including the CDC, WHO, and SHEA recommend nasal decolonization prior to major surgeries to reduce infection risk.

Unlike topical antibiotics such as mupirocin, Steriwave claims to eradicate a broader range of nasal pathogens, including drug-resistant strains, without fostering antimicrobial resistance.

Surgical site infections following major surgeries can extend hospital stays by nearly 10 days and carry approximately 3% excess mortality, based on information provided in the company statement.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.